Skip to main content
Equibles

UBS Group AG

Position in AXGN — Axogen, Inc.

CIK 1610520 ZURICH, V8
Back to AXGN Full portfolio

Position in AXGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$38,624,492
+$34,840,385 QoQ
Shares Held
836,209
+632.1% QoQ
Ownership
1.56%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#19
of 253 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in AXGN Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

UBS Group AG holds $4,686,473,125 across 138 Medical Devices names. AXGN ranks #20 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BSX
Boston Scientific Corp
 16,352,420 $697,921,281
2 ABT
Abbott Laboratories
 7,356,093 $667,491,874
3 SYK
Stryker Corp
 1,909,680 $601,243,647
4 MDT
Medtronic plc
 5,551,443 $434,289,383
5 DXCM
Dexcom Inc
 6,065,779 $408,530,211
6 ZBH
Zimmer Biomet Holdings, Inc.
 2,758,615 $237,489,163
7 PEN
Penumbra Inc
 703,822 $222,231,795
8 EW
Edwards Lifesciences Corp
 2,350,656 $212,640,338

All Filings in AXGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $38,624,492 836,209
2026-03-31 $3,784,107 114,220
2025-12-31 $2,971,162 90,778
2025-09-30 $2,038,344 114,257
2025-06-30 $1,301,261 119,932
2025-03-31 $1,644,760 88,906
2024-12-31 $1,396,712 84,752
2024-09-30 $267,893 19,108
2024-06-30 $93,142 12,865
2024-03-31 $338,592 41,957
2023-12-31 $305,266 44,695
2023-09-30 $123,355 24,671
2023-06-30 $359,813 39,410
2023-03-31 $281,079 29,744
2022-12-31 $257,742 25,826
2022-09-30 $208,635 17,503
2022-06-30 $147,050 17,955
2022-03-31 $163,515 20,594
2021-12-31 $340,194 36,307
2021-09-30 $253,353 16,035
2021-06-30 $375,257 17,365
2021-03-31 $596,311 29,433
2020-12-31 $415,870 23,233
2020-09-30 $179,438 15,429
2020-06-30 $259,855 28,123
2020-03-31 $365,809 35,174